Erythropoietin, progenitors, and repair

Kidney International

Volumn 72, Issue SUPPL. 107, 2007, Pages

  Aydin, Z ^a   Duijs, J ^a   Bajema, I M ^a   Van Zonneveld, A J ^a   Rabelink, T J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endothelial progenitor cell; Endothelium; Erythropoietin; Erythropoietin receptor; Renal failure

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GELATINASE B; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; CELL PROTECTION; CELL SURVIVAL; DRUG TARGETING; ENDOTHELIUM CELL; HEMATOPOIESIS; HEMORRHAGIC SHOCK; HUMAN; ISCHEMIA; KIDNEY CIRCULATION; KIDNEY FUNCTION; KIDNEY INFARCTION; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; LIMB ISCHEMIA; MOLECULAR DYNAMICS; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; STEM CELL; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM; ANIMAL; CYTOLOGY; DRUG EFFECT; KIDNEY; PHYSIOLOGY; REGENERATION;

ANIMALS; CELL SURVIVAL; ENDOTHELIAL CELLS; ERYTHROPOIETIN; HUMANS; KIDNEY; RECEPTORS, ERYTHROPOIETIN; REGENERATION; STEM CELLS;

EID: 38449122233     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002483     Document Type: Article

References (35)

1. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83: 59-67.
2. Arcasoy MO, Jiang X. Co-operative signalling mechanisms required for erythroid precursor expansion in response to erythropoietin and stem cell factor. Br J Haematol 2005; 130: 121-129.
3. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-820.
4. Brines M, Cerami A. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci 2005; 6: 484-494.
5. Sharples EJ, Yaqoob MM. Erythropoietin and acute renal failure. Semin Nephrol 2006; 26: 325-331.
6. Aydin Z, van Zonneveld AJ, de Fijter JW, Rabelink TJ. New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant 2007; 22: 342-346.
7. Beleslin-Cokic BB, Cokic VP, Yu X et al. Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells. Blood 2004; 104: 2073-2080.
8. Brodsky SV, Yamamoto T, Tada T et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002; 282: F1140-F1149.
9. d'Uscio LV, Smith LA, Santhanam AV et al. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension 2007; 49: 1142-1148.
10. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. New Engl J Med 2006; 355: 2085-2098.
11. Drueke TB, Locatelli F, Clyne N et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. New Engl J Med 2006; 355: 2071-2084.
12. Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the longacting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012.
13. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124.
14. Fioretto P, Steffes MW, Sutherland DE et al. Reversal of lesions of diabetic nephropathy after pancreas transplantation. New Engl J Med 1998; 339: 69-75.
15. Rookmaaker MB, Smits AM, Tolboom H et al. Bone-marrow-derived cells contribute to glomerular endothelial repair in experimental glomerulonephritis. Am J Pathol 2003; 163: 553-562.
16. Haendeler J, Hoffmann J, Diehl JF et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004; 94: 768-775.
17. Nadasdy T, Laszik Z, Blick KE et al. Proliferative activity of intrinsic cell populations in the normal human kidney. J Am Soc Nephrol 1994; 4: 2032-2039.
18. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
19. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 2005; 106: 1525-1531.
20. Li J, Deane JA, Campanale NV et al. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis. Stem Cells 2007; 25: 697-706.
21. Kertesz N, Wu J, Chen TH et al. The role of erythropoietin in regulating angiogenesis. Dev Biol 2004; 276: 101-110.
22. Heeschen C, Aicher A, Lehmann R et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003; 102: 1340-1346.
23. Bahlmann FH, de Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926.
24. Urao N, Okigaki M, Yamada H et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 2006; 98: 1405-1413.
25. Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 2003; 9: 1370-1376.
26. Nishijima I, Nakahata T, Watanabe S et al. Hematopoietic and lymphopoietic responses in human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor transgenic mice injected with human GM-CSF. Blood 1997; 90: 1031-1038.
27. Goncalves F, Lacout C, Villeval JL et al. Thrombopoietin does not induce lineage-restricted commitment of Mpl-R expressing pluripotent progenitors but permits their complete erythroid and megakaryocytic differentiation. Blood 1997; 89: 3544-3553.
28. Lacout C, Dubart A, Vainchenker W, Dumenil D. Pluripotent stem cells constitutively expressing a normal erythropoietin receptor give rise to normal hematopoiesis in lethally irradiated recipient mice. Exp Hematol 1996; 24: 18-25.
29. McArthur GA, Longmore GD, Klingler K, Johnson GR. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR. Exp Hematol 1995; 23: 645-654.
30. Dubart A, Feger F, Lacout C et al. Murine pluripotent hematopoietic progenitors constitutively expressing a normal erythropoietin receptor proliferate in response to erythropoietin without preferential erythroid cell differentiation. Mol Cell Biol 1994; 14: 4834-4842.
31. Arcasoy MO, Maun NA, Perez L et al. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression. Eur J Haematol 2001; 67: 77-87.
32. Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801-1809.
33. Loomans CJ, Wan H, de Crom R et al. Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression. Arterioscler Thromb Vasc Biol 2006; 26: 1760-1767.
34. Nakano M, Satoh K, Fukumoto Y et al. Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice. Circ Res 2007; 100: 662-669.
35. Plotkin MD, Goligorsky MS. Mesenchymal cells from adult kidney support angiogenesis and differentiate into multiple interstitial cell types including erythropoietin-producing fibroblasts. Am J Physiol Renal Physiol 2006; 291: F902-F912.